Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologics for highly prevalent diseases, has entered into a research collaboration with Novo Nordisk to evaluate Lumen’s drug development and manufacturing platform in Novo Nordisk’s research and development activities within obesity and other metabolic disorders. Financial terms were not disclosed.   The collaboration builds on previous research pointing to a diversity of relevant biology within the gastrointe...